US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Perpetuals.com Ltd

3.10

-0.0800-2.52%

Post-market: 3.120.0200+0.65%19:30 EDT

Volume:13.91K

Turnover:42.98K

Market Cap:21.00M

PE:-3.92

High:3.28

Open:3.17

Low:2.95

Close:3.18

52wk High:8.83

52wk Low:1.90

Shares:6.77M

Float Shares:4.36M

Volume Ratio:0.68

T/O Rate:0.32%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.7902

EPS(LYR):-0.5960

ROE:-98.99%

ROA:-52.19%

PB:4.16

PE(LYR):-5.20

Loading ...

Overview Company News Filings

Perpetuals.com gains CySEC approval for MiFID II license expansion; MTF adds direct client order execution

TETRA PAK OPENS PRODUCT DEVELOPMENT CENTRE IN THAILAND, UNLOCKING A WORLD OF POSSIBILITIES FOR FOOD AND BEVERAGE INNOVATORS ACROSS ASIA PACIFIC

Perpetuals.com CEO Patrick Gruhn to Present at Emerging Growth Conference

Perpetuals.com Ltd. Co-CEO and Director Patrick Gruhn Files Initial Beneficial Ownership Statement

Perpetuals.com Ltd. director Matthew Anthony Nicoletti files initial beneficial ownership statement

Perpetuals.com Ltd. Director Jason David Sawyer Files Initial Beneficial Ownership Statement

Perpetuals.com Ltd. Director Michael Anthony Hilmer Files Initial Beneficial Ownership Statement

Perpetuals.com Ltd. files initial beneficial ownership statement for Director Masahiro Tominaga

Avacta Announces Preclinical and Translational Presentations of pre|CISION® Platform Candidates at the 2026 AACR Annual Conference

Press Release: Cellectar Biosciences Reports Financial Results for Year Ended 2025 and Provides Corporate Updates

Perpetuals.com COO Naoki Yokota and CDO Tsubasa Nakamura Resign

Cellectar Biosciences to Report Full Year Financial Results and Host a Conference Call on Wednesday, March 4, 2026

Perpetuals.com launches Ledgera, PerpetualPay.Net platforms

Avacta's pre|CISION Mechanism for Payload Delivery Shows Key Advantages Compared to an Antibody Drug Conjugate in Innovative AI-Driven Analysis

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/PDC/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PDC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PDC\",,,,,undefined,":{"symbol":"PDC","market":"US","secType":"STK","nameCN":"Perpetuals.com Ltd","latestPrice":3.1,"timestamp":1787342400000,"preClose":3.18,"halted":0,"volume":13910,"hourTrading":{"tag":"盘后","latestPrice":3.12,"preClose":3.1,"latestTime":"19:30 EDT","volume":313,"amount":976.12,"timestamp":1787355006767,"change":0.02,"changeRate":0.006452,"amplitude":0.006452},"delay":0,"changeRate":-0.025157232704402538,"floatShares":4362600,"shares":6774500,"eps":-0.790182,"marketStatus":"Market Closed","change":-0.08,"latestTime":"08-21 16:00:00 EDT","open":3.17,"high":3.28,"low":2.95,"amount":42975.856105,"amplitude":0.103774,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.790182,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787558400000},"marketStatusCode":7,"adr":0,"adrRate":5,"listingDate":1690257600000,"exchange":"NASDAQ","adjPreClose":3.18,"preHourTrading":{"tag":"盘前","latestPrice":3.21,"preClose":3.18,"latestTime":"07:00 EDT","volume":2,"amount":6.49,"timestamp":1787310006943,"change":0.03,"changeRate":0.009434,"amplitude":0.022013},"postHourTrading":{"tag":"盘后","latestPrice":3.12,"preClose":3.1,"latestTime":"19:30 EDT","volume":313,"amount":976.12,"timestamp":1787355006767,"change":0.02,"changeRate":0.006452,"amplitude":0.006452},"volumeRatio":0.6816956604891597},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PDC\",,,,,undefined,":{"symbol":"PDC","floatShares":4362600,"roa":"-52.19%","roe":"-98.99%","lyrEps":-0.596009,"volumeRatio":0.6816956604891597,"shares":6774500,"dividePrice":0,"high":3.28,"amplitude":0.103774,"preClose":3.18,"low":2.95,"week52Low":1.9,"pbRate":"4.16","psRate":"13.62","week52High":8.83,"institutionHeld":0,"latestPrice":3.1,"eps":-0.790182,"divideRate":0,"volume":13910,"delay":0,"ttmEps":-0.790182,"open":3.17,"prevYearClose":6.475,"prevWeekClose":3.05,"prevMonthClose":3.34,"prevQuarterClose":5.9,"fiveDayClose":3.05,"twentyDayClose":3.6,"sixtyDayClose":6.6},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PDC\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-05-16","symbol":"PDC","defaultRemindTime":1715866200000,"type":"split","dateTimestamp":1715832000000,"forFactor":5,"toFactor":1,"ratio":5}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PDC\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PDC\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/PDC\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"PDC","date":"2026-08-21","current":-3.923147,"percent":0.868966,"low":-20.799035,"twenty":-13.901725,"median":-9.813125,"eighty":-8.565167,"high":-7.275042,"avg":-10.970893,"sd":2.757926,"marketCap":21543027},"quantilePoints":[{"date":"2026-01-23","current":-12.841505,"twenty":-12.726719,"median":-12.554539,"eighty":-12.382359,"marketCap":20820140},{"date":"2026-01-30","current":-9.396756,"twenty":-12.329049,"median":-11.675543,"eighty":-10.201718,"marketCap":15771446},{"date":"2026-02-06","current":-7.275042,"twenty":-12.149167,"median":-9.714799,"eighty":-8.086801,"marketCap":11897223},{"date":"2026-02-13","current":-8.985188,"twenty":-11.515878,"median":-8.985188,"eighty":-7.549471,"marketCap":15130827},{"date":"2026-02-20","current":-8.855994,"twenty":-10.87722,"median":-8.985188,"eighty":-7.579088,"marketCap":14673241},{"date":"2026-02-27","current":-8.742983,"twenty":-10.032842,"median":-8.830662,"eighty":-7.735212,"marketCap":14368184},{"date":"2026-03-06","current":-9.337263,"twenty":-10.032842,"median":-8.985188,"eighty":-8.021273,"marketCap":15191838},{"date":"2026-03-13","current":-9.688387,"twenty":-9.991079,"median":-9.288813,"eighty":-8.290652,"marketCap":15618918},{"date":"2026-03-20","current":-9.233278,"twenty":-9.991079,"median":-9.314811,"eighty":-8.348912,"marketCap":14993551},{"date":"2026-03-27","current":-9.069316,"twenty":-9.96573,"median":-9.348389,"eighty":-8.474222,"marketCap":14581724},{"date":"2026-04-02","current":-9.313761,"twenty":-9.884139,"median":-9.348389,"eighty":-8.689231,"marketCap":15008804},{"date":"2026-04-10","current":-9.533008,"twenty":-9.74834,"median":-9.359515,"eighty":-8.70742,"marketCap":15374872},{"date":"2026-04-17","current":-12.673274,"twenty":-9.884139,"median":-9.362202,"eighty":-8.546978,"marketCap":20438819},{"date":"2026-04-24","current":-13.088049,"twenty":-10.217704,"median":-9.396756,"eighty":-8.70742,"marketCap":21079438},{"date":"2026-05-01","current":-15.050104,"twenty":-11.793949,"median":-9.471088,"eighty":-8.745021,"marketCap":24648605},{"date":"2026-05-08","current":-14.948137,"twenty":-12.890814,"median":-9.496239,"eighty":-8.793369,"marketCap":24526582},{"date":"2026-05-15","current":-13.305836,"twenty":-13.354923,"median":-9.542177,"eighty":-8.845861,"marketCap":21598035},{"date":"2026-05-22","current":-11.365513,"twenty":-13.169042,"median":-9.675854,"eighty":-8.876909,"marketCap":21140450},{"date":"2026-05-29","current":-14.128136,"twenty":-13.74972,"median":-9.719101,"eighty":-8.895541,"marketCap":26275960},{"date":"2026-06-05","current":-12.076178,"twenty":-13.8801,"median":-9.813125,"eighty":-8.952904,"marketCap":22349404},{"date":"2026-06-12","current":-14.872027,"twenty":-13.8801,"median":-9.991079,"eighty":-9.00144,"marketCap":27440229},{"date":"2026-06-18","current":-14.520969,"twenty":-14.245743,"median":-10.18842,"eighty":-9.035091,"marketCap":26709707},{"date":"2026-06-26","current":-11.614912,"twenty":-14.356284,"median":-10.79484,"eighty":-9.128052,"marketCap":21276450},{"date":"2026-07-02","current":-13.769243,"twenty":-14.446364,"median":-10.952611,"eighty":-9.21958,"marketCap":25339979},{"date":"2026-07-10","current":-12.205639,"twenty":-14.446364,"median":-11.365513,"eighty":-9.239186,"marketCap":32585522},{"date":"2026-07-17","current":-8.962642,"twenty":-14.389601,"median":-10.952611,"eighty":-9.21958,"marketCap":23914115},{"date":"2026-07-24","current":-9.476284,"twenty":-14.254526,"median":-10.71246,"eighty":-9.09917,"marketCap":25065786},{"date":"2026-07-31","current":-9.145848,"twenty":-14.247303,"median":-10.285858,"eighty":-9.069924,"marketCap":24862550},{"date":"2026-08-07","current":-7.600862,"twenty":-14.243402,"median":-10.102078,"eighty":-8.962642,"marketCap":20797828},{"date":"2026-08-14","current":-7.895877,"twenty":-14.128136,"median":-9.96573,"eighty":-8.855994,"marketCap":21475282},{"date":"2026-08-21","current":-7.890223,"twenty":-13.901725,"median":-9.813125,"eighty":-8.565167,"marketCap":21543027}],"updateTime":1787510303601},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PDC\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2622728826","title":"Perpetuals.com gains CySEC approval for MiFID II license expansion; MTF adds direct client order execution","url":"https://stock-news.laohu8.com/highlight/detail?id=2622728826","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622728826?lang=en_us&edition=fundamental","pubTime":"2026-03-27 20:05","pubTimestamp":1774613142,"startTime":"0","endTime":"0","summary":"CySEC approved Perpetuals’ MiFID II license expansion to include reception and transmission of orders and execution of orders on behalf of clients.The approval allows clients to onboard directly with the MTF operator without an external broker.Perpetuals also replaced its external clearing house with proprietary clearing infrastructure.The expanded license is passportable across the European Economic Area.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260327:nNDLjgkjH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PDC","BK4123"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622116898","title":"TETRA PAK OPENS PRODUCT DEVELOPMENT CENTRE IN THAILAND, UNLOCKING A WORLD OF POSSIBILITIES FOR FOOD AND BEVERAGE INNOVATORS ACROSS ASIA PACIFIC","url":"https://stock-news.laohu8.com/highlight/detail?id=2622116898","media":"prnewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622116898?lang=en_us&edition=fundamental","pubTime":"2026-03-27 11:15","pubTimestamp":1774581300,"startTime":"0","endTime":"0","summary":"With the focus on liquid-based food and beverage categories, the new Product Development Centre brings world-class pilot production capabilities and end-to-end innovation support closer to food and beverage manufacturers across the regionSINGAPORE, March 27, 2026 /PRNewswire/ -- Tetra Pak has officially opened its latestProduct Development Centre  in Rayong, Thailand, to support food and beverage manufacturers across Asia Pacific  in taking new products from concept to production.Southeast Asia, as one of the fastest-growing sub-regions within APAC, is seeing strong momentum in food and beverage innovation, driven by urbanisation, rising middle-class consumption and demand for healthier, functional products. This has driven functional beverage market launches across the region to grow in double digits of around 15% year-on-year.To meet this momentum, Tetra Pak has strengthened its innovation ecosystem in APAC to help food and beverage manufacturers in the region accelerate product deve","market":"other","thumbnail":"https://mma.prnewswire.com/media/2943867/Left__Julia_Luscher__Middle__Anna_Hammargren__Rignt__Kanchai_Thepvorachai.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/2943867/Left__Julia_Luscher__Middle__Anna_Hammargren__Rignt__Kanchai_Thepvorachai.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/tetra-pak-opens-product-development-centre-in-thailand-unlocking-a-world-of-possibilities-for-food-and-beverage-innovators-across-asia-pacific-302726926.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PAK","BK4024","PDC","ASIA","APAC","FOR","BK4123"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620734637","title":"Perpetuals.com CEO Patrick Gruhn to Present at Emerging Growth Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2620734637","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620734637?lang=en_us&edition=fundamental","pubTime":"2026-03-20 22:04","pubTimestamp":1774015442,"startTime":"0","endTime":"0","summary":"Perpetuals said CEO Patrick Gruhn will present and take investor questions at the Emerging Growth Conference on April 1, 2026, at 12:35 p.m. ET.An archived replay will be available at .","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260320:nNDL9vnlfF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PDC","BK4123"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620296231","title":"Perpetuals.com Ltd. Co-CEO and Director Patrick Gruhn Files Initial Beneficial Ownership Statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2620296231","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620296231?lang=en_us&edition=fundamental","pubTime":"2026-03-19 07:51","pubTimestamp":1773877916,"startTime":"0","endTime":"0","summary":"Perpetuals.com reported an initial statement of beneficial ownership by Patrick Gruhn, a director and Co-Chief Executive Officer. The filing listed 1.29 million ordinary shares beneficially owned directly. It also listed 22.53 million Series P preferred shares beneficially owned directly.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Perpetuals.com Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 18, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nNDL290krT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4123","PDC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620106296","title":"Perpetuals.com Ltd. director Matthew Anthony Nicoletti files initial beneficial ownership statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2620106296","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620106296?lang=en_us&edition=fundamental","pubTime":"2026-03-19 07:46","pubTimestamp":1773877574,"startTime":"0","endTime":"0","summary":"Perpetuals.com reported an initial statement of beneficial ownership by director Matthew Nicoletti. The filing listed indirect beneficial ownership of 138,590 ordinary shares through One9. It also reported indirect beneficial ownership of 2.41 million Series P preferred shares through One9.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Perpetuals.com Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 18, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nNDLxhCsp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4123","PDC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620826235","title":"Perpetuals.com Ltd. Director Jason David Sawyer Files Initial Beneficial Ownership Statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2620826235","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620826235?lang=en_us&edition=fundamental","pubTime":"2026-03-19 04:12","pubTimestamp":1773864722,"startTime":"0","endTime":"0","summary":"Perpetuals.com filed an initial statement of beneficial ownership on March 18, 2026. The filing identified Jason David Sawyer as a director. The form stated that no securities are beneficially owned by Sawyer.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Perpetuals.com Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 18, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nNDL3HgVzK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PDC","BK4123"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620232138","title":"Perpetuals.com Ltd. Director Michael Anthony Hilmer Files Initial Beneficial Ownership Statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2620232138","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620232138?lang=en_us&edition=fundamental","pubTime":"2026-03-18 18:41","pubTimestamp":1773830474,"startTime":"0","endTime":"0","summary":"Perpetuals.com reported an initial statement of beneficial ownership filed by director Michael Anthony Hilmer. The filing listed no securities as beneficially owned by Hilmer. The date of the event requiring the statement was March 18, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Perpetuals.com Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 18, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nNDLc2jSSn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PDC","BK4123"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620696232","title":"Perpetuals.com Ltd. files initial beneficial ownership statement for Director Masahiro Tominaga","url":"https://stock-news.laohu8.com/highlight/detail?id=2620696232","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620696232?lang=en_us&edition=fundamental","pubTime":"2026-03-18 18:39","pubTimestamp":1773830371,"startTime":"0","endTime":"0","summary":"Masahiro Tominaga filed an initial statement of beneficial ownership on Form 3 for Perpetuals.com . Tominaga reported his role as a director. The filing stated that no securities are beneficially owned.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Perpetuals.com Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 18, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nNDLqN0jW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4123","PDC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620446068","title":"Avacta Announces Preclinical and Translational Presentations of pre|CISION® Platform Candidates at the 2026 AACR Annual Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2620446068","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620446068?lang=en_us&edition=fundamental","pubTime":"2026-03-17 15:00","pubTimestamp":1773730800,"startTime":"0","endTime":"0","summary":"LONDON and PHILADELPHIA, March  17, 2026 (GLOBE NEWSWIRE) -- Avacta Therapeutics (AIM: AVCT, \"the Company\", \"Avacta\"), a clinical stage biopharmaceutical company developing pre|CISION,a tumor-activate","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/17/3256882/0/en/Avacta-Announces-Preclinical-and-Translational-Presentations-of-pre-CISION-Platform-Candidates-at-the-2026-AACR-Annual-Conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PDC","BK4123"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616537654","title":"Press Release: Cellectar Biosciences Reports Financial Results for Year Ended 2025 and Provides Corporate Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2616537654","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616537654?lang=en_us&edition=fundamental","pubTime":"2026-03-04 20:15","pubTimestamp":1772626500,"startTime":"0","endTime":"0","summary":"On track to submit Conditional Marketing Authorization for iopofosine I 131 to European Medicines Agency in Q3 2026 for potential 2027 EU commercialization as a treatment for Waldenstrm Macroglobulinemia. Initiated Phase 1b dose finding study for CLR 125 in Triple Negative Breast Cancer with early data expected by mid-year 2026. \"2025 was a productive year for Cellectar, marked by disciplined execution across our pipeline and meaningful clinical, regulatory, and operational achievements,\" said James Caruso, president and CEO of Cellectar. \"We advanced iopofosine I-131 toward its planned mid-2026 Conditional Marketing Authorization  submission in Europe, supported by a strong clinical dataset and productive dialogue with both the European and U.S. regulatory agencies. In parallel, we continued to shape the future of our radiotherapeutic platform with the initiation of our Phase 1b CLR 125 study in triple negative breast cancer and strengthened our supply chain and intellectual property ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2271345857.HKD","LU0057025933.USD","LU2023250843.SGD","LU2238339852.HKD","LU2023250504.SGD","BK4099","LU2229751404.USD","LU2125910336.SGD","LU0689626769.HKD","LU0511384066.AUD","LU2362541513.USD","LU0289961442.SGD","PDC","EMA","CMA","LU2111349929.HKD","03160","LU1430594728.SGD","LU1989772923.USD","BK4566","WM","LU1623119135.USD","LU2028103732.USD","LU0069063385.USD","LU2413666699.HKD","BK4139","LU0289960550.SGD","LU2211814178.USD","CLRB","LU1712237335.SGD","LU0158827948.USD","LU1974910355.USD","LU2023251221.USD","LU2298064838.USD","LU2355687059.USD","CNS","LU1585245621.USD","BK4534","LU2308191902.HKD","LU1989772840.SGD","LU2089283258.USD","BK4533","LU0124676726.USD","LU2106854487.HKD","LU2362540622.SGD","TM","LU2125910179.SGD","LU1721428933.USD","BK4135","LU0175139822.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616464372","title":"Perpetuals.com COO Naoki Yokota and CDO Tsubasa Nakamura Resign","url":"https://stock-news.laohu8.com/highlight/detail?id=2616464372","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616464372?lang=en_us&edition=fundamental","pubTime":"2026-03-04 05:59","pubTimestamp":1772575165,"startTime":"0","endTime":"0","summary":"Perpetuals.com Ltd. said Chief Operating Officer Naoki Yokota and Chief Design Officer Tsubasa Nakamura will step down from their roles effective at the end of February 2026 . The company said the resignations are for personal reasons and are not related to any disagreement over its operations, policies, or practices.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Perpetuals.com Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 03, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260303:nNDL1k0KPZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4123","PDC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614080335","title":"Cellectar Biosciences to Report Full Year Financial Results and Host a Conference Call on Wednesday, March 4, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2614080335","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614080335?lang=en_us&edition=fundamental","pubTime":"2026-02-25 21:05","pubTimestamp":1772024700,"startTime":"0","endTime":"0","summary":"FLORHAM PARK, N.J., Feb.  25, 2026  (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery and development of drugs fo","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/02/25/3244575/29076/en/Cellectar-Biosciences-to-Report-Full-Year-Financial-Results-and-Host-a-Conference-Call-on-Wednesday-March-4-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4533","BK4081","LU0158827948.USD","LU2362541513.USD","CLRB","LU1989772923.USD","EMA","CNS","LU2362541273.HKD","LU1917777945.USD","LU2362540622.SGD","LU2463526074.USD","PDC","LU0472753341.HKD","LU1712237335.SGD","BK4588","LU2089283258.USD","LU1939255532.USD","BK4135","LU2298064838.USD","BK4181","LU1892829315.USD","LU0289960550.SGD","LU2106854487.HKD","LU1430594728.SGD","BK4566","LU2028103732.USD","LU1721428933.USD","LU0289739343.SGD","LU0289961442.SGD","LU2041044095.USD","LU2089284900.SGD","HST","LU2229751404.USD","BK4139","BK4534","LU0347712357.USD","LU1585245621.USD","LU1989772840.SGD","LU0511384066.AUD","LU2413666426.HKD","LU2023251221.USD","LU0069063385.USD","LU1923621640.USD","LU2125910336.SGD","LU2211814178.USD","WM","LU2238339852.HKD","LU0158827781.USD","LU2089279066.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2613710207","title":"Perpetuals.com launches Ledgera, PerpetualPay.Net platforms","url":"https://stock-news.laohu8.com/highlight/detail?id=2613710207","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613710207?lang=en_us&edition=fundamental","pubTime":"2026-02-24 22:26","pubTimestamp":1771943190,"startTime":"0","endTime":"0","summary":"Perpetuals.com (PDC) launched two proprietary, revenue-generating platforms: Ledgera and PerpetualPay.Net. Both deliver quantum-resilient security ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/perpetuals-com-launches-ledgera-perpetualpay-net-platforms-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/perpetuals-com-launches-ledgera-perpetualpay-net-platforms-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4123","PDC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2613797474","title":"Avacta's pre|CISION Mechanism for Payload Delivery Shows Key Advantages Compared to an Antibody Drug Conjugate in Innovative AI-Driven Analysis","url":"https://stock-news.laohu8.com/highlight/detail?id=2613797474","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613797474?lang=en_us&edition=fundamental","pubTime":"2026-02-24 15:00","pubTimestamp":1771916400,"startTime":"0","endTime":"0","summary":"Experimental data from FAP-Exd (AVA6103) demonstrates a more favorable profile compared to the marketed Antibody Drug Conjugate (ADC) Enhertu Clinical trial with AVA6103 is expected to be initiated in","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/02/24/3243168/0/en/Avacta-s-pre-CISION-Mechanism-for-Payload-Delivery-Shows-Key-Advantages-Compared-to-an-Antibody-Drug-Conjugate-in-Innovative-AI-Driven-Analysis.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4123","BK4181","BK4080","ADC","PDC","BK4231","PK","BK4218"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":4,"totalSize":74,"code":"91000000","status":"200"}]}}